Repligen Corporation (RGEN): Stock Guide for Investors
Key Information
Ticker Symbol: RGEN
Exchange: Nasdaq
Industry: Biotechnology
Real-Time Stock Quote
Click here for the latest real-time stock quote for Repligen Corporation (RGEN).
Stock Performance and History
- RGEN stock has had a strong performance over the past year, rising by over 100%.
- The company has a market capitalization of over $10 billion.
- RGEN's revenue has grown steadily in recent years, with a strong revenue growth rate of over 20% in the past year.
Financial Data and Analysis
Repligen Corporation's financial data and analysis can be found on websites such as Yahoo Finance and MarketWatch.
News and Insights
- RGEN has been in the news recently for its acquisition of Vybex Animal Health.
- Analysts are generally positive on RGEN stock, with a consensus recommendation of "buy".
- The company is expected to continue to perform well in the future, with a projected revenue growth rate of over 15% in the next year.
Conclusion
Repligen Corporation (RGEN) is a leading biotechnology company with a strong track record of growth and profitability. The company's stock has performed well over the past year and is expected to continue to perform well in the future.
Komentar